WEBINAR: The IRA Playbook for Current & Future Negotiators - Leveraging the Lessons Learned for June 2025 and Beyond
Access to this On Demand webinar is by request only. Click here to request access.
What’s changed between IPAY 2026 and IPAY 2027?
And what might come next as manufacturers prepare for IPAY 2028 and beyond?
This webinar brings together advisors from Verpora and Manatt Health to explore how CMS’s approach has evolved, what brands currently in the process should prioritise, and how future negotiation cycles may unfold.
Unlike our first IPAY webinar, which focused on what had already taken place, this session looks forward — offering perspective and speculation on what’s next in the IRA negotiation landscape.
In this session:
How CMS’s negotiation tactics have shifted
Strategic considerations for manufacturers currently involved in IPAY 2027
What to anticipate from IPAY 2028 and future cycles
Brief reflections on broader policy signals, including Trump’s recent Executive Orders
Preparing for the next wave of the Medicare Drug Price Negotiations? Use Verpora’s knowledge to build a stronger negotiation team
If you would like to extend the conversation with the Verpora and/or Manatt Health team, please email your enquiry to info@verpora.com
Speakers
Nick Merryfield
CEO,
Verpora
LinkedIn
Omar Ali
Head of Payers, Verpora
LinkedIn
Chris Webber
Head of Negotiation, Verpora
LinkedIn
Webinar Disclaimer: This presentation is for discussion purposes only. No part of this presentation is intended as legal advice. This presentation is based on non-confidential, publicly sourced intelligence. Views expressed by the speakers are personal opinion and should not be attributed to anyone else. No part of this webinar may be reproduced for commercial purposes without the express permission of Verpora and Manatt Health.
